Outcome of urinary tract infections caused by extended spectrum β-lactamase-producing enterobacteriaceae in children

Pediatric Infectious Disease Journal

Volumn 30, Issue 8, 2011, Pages 707-710

  Tratselas, Athanasios ^a   Iosifidis, Elias ^a   Ioannidou, Maria ^a   Saoulidis, Stamatis ^a   Kollios, Konstantinos ^a   Antachopoulos, Charalampos ^a   Sofianou, Danai ^b   Roilides, Emmanuel J ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

Author keywords

case control study; ESBL bacteria; Escherichia coli; Klebsiella pneumoniae

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; FEMALE; HUMAN; KIDNEY SCAR; MALE; NONHUMAN; PRIORITY JOURNAL; SCHOOL CHILD; URINARY TRACT INFECTION;

EID: 79960643014     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31820eae6a     Document Type: Article

References (10)

1. Tumbarello M, Spanu T, Sanguinetti M, et al. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother. 2006;50:498-504. (Pubitemid 43190958)
2. Kang CI, Kim SH, Kim DM, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2004; 25:860-867. (Pubitemid 40036764)
3. Lautenbach E, Patel JB, Bilker WB, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32:1162-1171. (Pubitemid 32390110)
4. Kim YK, Pai H, Lee HJ, et al. Bloodstream infections by extendedspectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother. 2002;46:1481-1491. (Pubitemid 34415332)
5. Zaoutis TE, Goyal M, Chu JH, et al. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics. 2005;115:942-949.
6. Hyle EP, Lipworth AD, Zaoutis TE, et al. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: variability by site of infection. Arch Intern Med. 2005;165:1375-1380. (Pubitemid 40973420)
7. Kang CI, Kim SH, Park WB, et al. Bloodstream infections due to extendedspectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother. 2004; 48:4574-4581.
8. Paterson DL, Ko WC, Von Gottberg A, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extendedspectrum beta-lactamases. Clin Infect Dis. 2004;39:31-37. (Pubitemid 38879546)
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5 and informational supplement M100-S10. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
10. Bundtzen RW, Toothaker RD, Nielson OS, et al. Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of highpressure liquid chromatography and microbiological assays. Antimicrob Agents Chemother. 1981;19:443-449. (Pubitemid 11119389)